NASDAQ$AVAH
Aveanna Healthcare Holdings Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open
Briefing
Aveanna Healthcare reported Q4 2025 revenue of $662.5M with GAAP diluted EPS of $0.80 and adjusted EPS of $0.17.
Revenue increased 27.4% to $662.5M driven by growth across PDS, home health, and medical solutions segments. Adjusted EBITDA rose 54% to $85.0M (12.8% margin). GAAP net income was $178.8M ($0.80 diluted EPS) reflecting non-recurring items; adjusted diluted EPS was $0.17. FY2025 revenue grew 20.2% to $2.43B with free cash flow of $131M.
- Q4 revenue $662.5M (+27.4% YoY).
- Q4 Adjusted EBITDA $85M (+54%); margin 12.8%.
- GAAP diluted EPS $0.80; adjusted diluted EPS $0.17.
- FY2025 revenue $2.43B (+20.2%); free cash flow $131M.
- Pending Family First acquisition not in FY2026 guidance.
Headline financials
Revenue & EPS history
Aveanna Healthcare Holdings Inc · Revenue · Quarterly
$663M
Forward guidance
Management maintained FY2026 revenue guidance of $2.54–2.56B and Adjusted EBITDA of $318–322M, excluding the pending Family First transaction.
Tailwinds
- FY2026 revenue guide $2.54–2.56B maintained.
- Adjusted EBITDA guide $318–322M.
- Thrive Skilled Pediatric integration complete; M&A capacity improved.
- FY2025 Adjusted EBITDA $321M (+75% YoY).
Headwinds
- 14-week Q4 2025 vs 13-week prior year affects comparability.
- GAAP EPS inflated by non-recurring items vs adjusted $0.17.
- Family First closing and integration risks not in guide.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 14 quarterly earnings reports · overlaid with Q4 2025
+2.7%
Avg return
Earnings day
+5.0%
Avg return
5 days after
+8.2%
Avg return
30 days after
56%
9 / 16 earnings
Positive
+32.2%
Q2 2024
Best reaction
-8.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.4% | +12.2% | +4.4% | |
| Q4 2025 | -8.2% | -4.3% | -2.0% | |
| Q3 2026 | -6.3% | -2.5% | +1.1% | |
| Q1 2025 | +14.1% | +21.6% | +14.3% | |
| Q3 2024 | +16.2% | +20.6% | +11.4% | |
| Q2 2024 | +32.2% | +34.4% | +58.0% | |
| Q1 2024 | +2.5% | +6.2% | +2.9% | |
| Q3 2023 | +2.0% | +26.2% | +75.8% | |
| Q2 2023 | +3.4% | +0.6% | -21.0% | |
| Q1 2023 | +3.8% | +5.7% | +26.7% | |
| Q3 2022 | -8.3% | -19.4% | -13.7% | |
| Q2 2022 | -8.6% | -9.1% | -12.9% | |
| Q1 2022 | -6.5% | +5.4% | +4.0% | |
| Q3 2021 | -3.1% | -16.5% | -25.9% | |
| Q2 2021 | +2.3% | -2.0% | -2.9% | |
| Q1 2021 | -1.8% | +0.9% | +10.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro